Oncolytics Biotech (ONCY) Misses Q3 EPS by 2c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Jefferies on QuidelOrtho (QDEL): 'we view a potential sale as a net positive'
• General Mills (GIS) call put ratio 2.6 calls to 1 put with a focus on July 37.50 calls into quarter results
• Freedom Broker Upgrades Satellogic, Inc. (SATL) to Buy